ScoreWhy is Alembic Pharmaceuticals Ltd. ?
1
Poor long term growth as Operating profit has grown by an annual rate -8.80% of over the last 5 years
2
Flat results in Dec 25
- INVENTORY TURNOVER RATIO(HY) Lowest at 2.79 times
- DEBT-EQUITY RATIO(HY) Highest at 0.28 times
- EPS(Q) Lowest at Rs 6.77
3
Below par performance in long term as well as near term
- Along with generating -10.88% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Alembic Pharma for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Alembic Pharma
-10.88%
-0.33
33.03%
Sensex
7.07%
0.61
11.53%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
6.44%
EBIT Growth (5y)
-8.78%
EBIT to Interest (avg)
19.71
Debt to EBITDA (avg)
0.93
Net Debt to Equity (avg)
0.25
Sales to Capital Employed (avg)
1.02
Tax Ratio
18.42%
Dividend Payout Ratio
37.06%
Pledged Shares
0
Institutional Holding
20.41%
ROCE (avg)
12.71%
ROE (avg)
11.80%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
24
Industry P/E
32
Price to Book Value
2.94
EV to EBIT
19.70
EV to EBITDA
14.63
EV to Capital Employed
2.55
EV to Sales
2.34
PEG Ratio
2.01
Dividend Yield
1.38%
ROCE (Latest)
12.61%
ROE (Latest)
11.93%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
PAT(Q)
At Rs 167.47 cr has Grown at 21.0%
-6What is not working for the Company
INVENTORY TURNOVER RATIO(HY)
Lowest at 2.79 times
DEBT-EQUITY RATIO(HY)
Highest at 0.28 times
EPS(Q)
Lowest at Rs 6.77
Loading Valuation Snapshot...
Here's what is working for Alembic Pharma
Profit After Tax (PAT) - Quarterly
At Rs 167.47 cr has Grown at 21.0%
Year on Year (YoY)MOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Here's what is not working for Alembic Pharma
Inventory Turnover Ratio- Half Yearly
Lowest at 2.79 times and Fallen
each half year in the last five half yearly periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Earnings per Share (EPS) - Quarterly
Lowest at Rs 6.77
in the last five quartersMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (Rs)
Debt-Equity Ratio - Half Yearly
Highest at 0.28 times
in the last five half yearly periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Non Operating Income - Quarterly
Highest at Rs 15.50 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
